TORONTO--(BUSINESS WIRE)--Medworxx Inc. (“Medworxx”) (TSXV:MWX), a leader in clinical patient flow, and compliance and education solutions, announced today that George Elliott has been appointed as the new Chairman of the Board of Directors of Medworxx, effective immediately. Bernard Webber has stepped down from the Chairman position; he will continue to serve Medworxx as a director.

“I look forward to focusing on aligning the Medworxx Board of Directors with the future growth potential of the company”

George Elliott has been a director, executive or advisor to public companies ranging from large commercial printing, mortgage servicing, constructions lending and research companies. He had a 35 year career with Canada’s largest law firms focusing on business development and relationship management. George is a graduate of the Directors Education Program at the Rotman School of Management, University of Toronto.

“Medworxx would like to express our sincere thanks to Bernard Webber, for his guidance and leadership. He has been instrumental in taking us this far, including through the transition from private to public company,” said Dan Matlow, President & CEO, Medworxx. “We are also pleased to welcome George Elliott to the position of Chairman and are confident that his experience with public companies will help guide our growth and success.”

“I look forward to focusing on aligning the Medworxx Board of Directors with the future growth potential of the company,” said George Elliott, Chairman of the Board. “The company, with its large Canadian footprint, UK presence, and global expansion plans is well positioned for growth in the coming years.”

About MedworxxMedworxx delivers health information solutions to over 350 hospitals internationally; including Canada, United States and United Kingdom. Medworxx helps hospitals meet patient flow challenges, and requirements in compliance and education. Medworxx Clinical Criteria – flagship of Medworxx Patient Flow that includes electronic bed board and independent assessment components – currently serves over 33% of the acute care beds in Canada. Founded in 2004, Medworxx is based in Toronto, ON, and publicly traded on the TSX Venture Exchange: MWX.Visit: www.medworxx.com

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Disclaimer

This press release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as competition, technological changes, the changing needs of hospitals, the financial condition of the Company’s current and potential customers, foreign currency exchange rates, as well as general economic conditions, which may cause the actual results, performance or achievements of the Corporation and Medworxx to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this press release. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.